IVIDATA Group SAS

Based in France, IVIDATA Group SAS operates as a consulting firm focusing on optimizing healthcare projects, offering specialized services in biometrics, clinical operations, and regulatory affairs to various stakeholders in the health sector. Founded in 2013, IVIDATA Group SAS is headquartered in Paris, France. The firm specializes in consulting services aimed at enhancing healthcare projects from clinical research to market launch. In March 2019, a majority stake in IVIDATA was acquired by Keensight Capital, Isai, and the company's management, enabling further expansion of its data services and digital transformation initiatives.

IVIDATA Life Sciences provides a comprehensive suite of consulting services designed to optimize and accelerate healthcare projects, focusing on three core areas: Biometrics & Data, Clinical Operations, and Regulatory Affairs & Vigilance. Their offerings include data management, biostatistics, real-world data generation, and regulatory compliance support, aimed at various stakeholders including pharmaceutical companies and medical device manufacturers across Europe. For the fiscal year 2022, IVIDATA Life Sciences reported a revenue of USD 4. 14 mn and an EBITDA of USD -3.

66 mn, generated primarily through consulting agreements with clients in the healthcare sector. Following the acquisition in March 2019, IVIDATA Group SAS plans to enhance its data services portfolio and digital transformation strategies globally. The recent investment will support the development of new consulting offerings and facilitate expansion into additional European markets by 2025, aiming to strengthen its position within the healthcare consulting sector.